We are live on ! Find out more
PSC

Prentiss Smith & Co Portfolio holdings

AUM $182M
1-Year Est. Return 26.44%
This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+26.44%
3 Year Est. Return
+63.89%
5 Year Est. Return
+57.29%
10 Year Est. Return
+270.92%
AUM
$173M
AUM Growth
-$17.9M
Cap. Flow
-$30.2M
Cap. Flow %
-17.43%
Top 10 Hldgs %
55.08%
Holding
288
New
38
Increased
28
Reduced
38
Closed
40

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$4.21M
2
CERN
Cerner Corp
CERN
+$1.19M
3
UMPQ
Umpqua Holdings Corp
UMPQ
+$656K
4
DHR icon
Danaher
DHR
+$524K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$443K

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$8.2M
2
UPS icon
United Parcel Service
UPS
+$6.58M
3
FFIV icon
F5
FFIV
+$6.21M
4
FSLR icon
First Solar
FSLR
+$3.71M
5
ORBK
Orbotech Ltd
ORBK
+$2.58M

Sector Composition

Rank Sector Weight
1 Healthcare 32.47%
2 Technology 20.82%
3 Communication Services 13.22%
4 Financials 11.36%
5 Industrials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RMD icon
201
ResMed
RMD
$34.7B
$10K 0.01%
125
– –
STPZ icon
202
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$524M
$10K 0.01%
+200
New +$10.4K
UNB icon
203
Union Bankshares
UNB
$117M
$10K 0.01%
200
– –
ABB
204
DELISTED
ABB Ltd
ABB
$9K 0.01%
+350
New +$8.37K
MAR icon
205
Marriott International
MAR
$91.5B
$8K ﹤0.01%
+74
New +$7.63K
SYNA icon
206
Synaptics
SYNA
$3.72B
$8K ﹤0.01%
200
– –
WPM icon
207
Wheaton Precious Metals
WPM
$69.6B
$8K ﹤0.01%
400
– –
IMGN
208
DELISTED
Immunogen Inc
IMGN
$8K ﹤0.01%
1,000
– –
UN
209
DELISTED
Unilever NV New York Registry Shares
UN
$8K ﹤0.01%
+132
New +$7.7K
AMP icon
210
Ameriprise Financial
AMP
$49.4B
$7K ﹤0.01%
+47
New +$6.56K
AIG icon
211
American International
AIG
$40.2B
$6K ﹤0.01%
100
– –
DXC icon
212
DXC Technology
DXC
$1.79B
$6K ﹤0.01%
77
– –
FTV icon
213
Fortive
FTV
$18B
$6K ﹤0.01%
125
+57
+84% +$2.37K
ICE icon
214
Intercontinental Exchange
ICE
$91.1B
$6K ﹤0.01%
+90
New +$5.93K
NWL icon
215
Newell Brands
NWL
$2.63B
$6K ﹤0.01%
+131
New +$6.41K
AFL icon
216
Aflac
AFL
$58.4B
$5K ﹤0.01%
124
– –
COP icon
217
ConocoPhillips
COP
$157B
$5K ﹤0.01%
100
– –
JCI icon
218
Johnson Controls International
JCI
$84.6B
$5K ﹤0.01%
125
– –
MET icon
219
MetLife
MET
$61.3B
$5K ﹤0.01%
96
-12
-11% -$584
PSX icon
220
Phillips 66
PSX
$97.4B
$5K ﹤0.01%
50
– –
LVLT
221
DELISTED
Level 3 Communications Inc
LVLT
$5K ﹤0.01%
+92
New +$5.13K
MZTI
222
The Marzetti Company
MZTI
$3.13B
$4K ﹤0.01%
30
– –
LITE icon
223
Lumentum
LITE
$80.3B
$4K ﹤0.01%
80
– –
MDT icon
224
Medtronic
MDT
$117B
$4K ﹤0.01%
+49
New +$4.07K
RYAAY icon
225
Ryanair
RYAAY
$29.1B
$4K ﹤0.01%
+98
New +$4.43K
7 8
9
10 11

Similar funds

TA
TPG Advisors Northfield, Illinois $182M AUM 18.36% 1-Year Est. Return
LAM
Lakewood Asset Management Naperville, Illinois $182M AUM 22.41% 1-Year Est. Return
MPW
Magnolia Private Wealth Philadelphia, Pennsylvania $182M AUM 21.95% 1-Year Est. Return
SRB
Shotwell Rutter Baer Lansing, Michigan $182M AUM 17.21% 1-Year Est. Return
BFP
Brewster Financial Planning Brooklyn, New York $182M AUM 15.59% 1-Year Est. Return
FNBOH
First National Bank of Hutchinson Hutchinson, Kansas $182M AUM 38.15% 1-Year Est. Return
SIM
Sterling Investment Management Tucson, Arizona $182M AUM 9.75% 1-Year Est. Return
CAM
Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return

Prentiss Smith & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Prentiss Smith & Co held 288 positions worth $173M, down 9.3% from $191M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Prentiss Smith & Co withdrew a net $30.2M in Q3 2017, closing 40 positions and reducing 38 holdings. Its most notable exit was F5, an estimated $6.21M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 26% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Prentiss Smith & Co opened a new position in Regeneron Pharmaceuticals worth $416K.

  • Prentiss Smith & Co's largest Q3 2017 buy was Regeneron Pharmaceuticals: 931 shares worth $416K.
  • Prentiss Smith & Co added most to Oracle in Q3 2017, an estimated $4.21M increase.
  • Prentiss Smith & Co's biggest Q3 2017 reduction was Verizon, cutting an estimated $8.2M.
  • Prentiss Smith & Co fully exited F5 in Q3 2017, selling an estimated $6.21M.
  • Prentiss Smith & Co's ten largest holdings make up 55% of its $173M portfolio in Q3 2017.
  • Prentiss Smith & Co opened 38 new positions and closed 40 in Q3 2017.
  • Prentiss Smith & Co's portfolio value fell 9.3% quarter-over-quarter to $173M.

Based on Prentiss Smith & Co's 13F filing for Q3 2017, filed 23 Oct 2017.